Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Am J Gastroenterol ; 91(7): 1351-4, 1996 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-8677993

RESUMEN

OBJECTIVES: To clarify 1) whether gastric emptying of a mixed meal is delayed in patients with gastroesophageal reflux and 2) the relationship between dyspeptic symptoms and delayed gastric emptying in refluxers. METHODS: Gastric emptying of a solid meal was studied by ultrasound in 25 patients with pathological esophageal acid exposure. Gastric emptying was then assessed in relation to upper digestive endoscopy, esophageal manometry, 24-h pH monitoring and quantification of symptoms of reflux- and dysmotility-like dyspepsia. RESULTS: Fifteen of 25 refluxers had esophagitis, and 15 were "dyspeptic". Refluxers exhibited a significant delay in gastric emptying compared with controls [307.6 (21.0) vs. 209 (10.4) min, p < 0.001). Patients with delayed emptying had low LES pressure [11.9 (2.1) vs. 18.6 (2.1) mm Hg, p < 0.05]. There was no correlation between delayed emptying and either pH monitoring or presence of esophagitis. There were no differences in any of the pH monitoring parameters between refluxers with and without coexisting dysmotility-like symptoms. CONCLUSIONS: Gastric emptying of a solid meal is markedly delayed in patients with gastroesophageal reflux. However, no direct causal link was found between delayed emptying and reflux. Our data suggest the presence of a motility disorder in gastroesophageal reflux which is not confined to the esophagogastric junction.


Asunto(s)
Dispepsia/fisiopatología , Vaciamiento Gástrico , Reflujo Gastroesofágico/fisiopatología , Adulto , Anciano , Análisis de Varianza , Dispepsia/diagnóstico por imagen , Esófago/fisiopatología , Femenino , Reflujo Gastroesofágico/diagnóstico por imagen , Humanos , Concentración de Iones de Hidrógeno , Masculino , Manometría/instrumentación , Manometría/métodos , Manometría/estadística & datos numéricos , Persona de Mediana Edad , Estómago/diagnóstico por imagen , Estómago/fisiopatología , Factores de Tiempo , Ultrasonografía
2.
Gut ; 36(6): 825-30, 1995 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-7615267

RESUMEN

Exogenous fibre added to liquid meals delays gastric emptying. Its effect on solid meals is uncertain, and nothing is known of the effect on gastric emptying of fibre naturally present in food. This study therefore looked at gastric emptying of two different solid meals in eight healthy subjects and their blood glucose responses. The meals were exactly equivalent except for the total dietary fibre content (high fibre 20 g, low fibre 4 g of dietary fibre per 1000 kcal) and supplied 870 kcal (700 kcal women), 47% of which was from carbohydrates, 36% from fats, and 17% from proteins. Ultrasonography was used to measure antral diameters before the meal (basal), immediately after it (time 0), and at 30, 60, 120, 180, 240, and 300 minutes. In addition, subjects filled in a questionnaire on their feelings of hunger, epigastric fullness, and satiety before the meal and at hourly intervals after it. Basal and maximal postprandial antral sections were similar for the two meals (basal section: 283.9 (29.5) v 340.9 (44.7) mm2 for the low and the high fibre meal, NS; maximal postprandial section: 1726 (101.9) v 1593 (120.4) mm2, NS). Total gastric emptying time was significantly reduced by fibre removal (186.0 (15.6) v 231.7 (17.3) minutes after the low and the high fibre meal, p < 0.05). Blood glucose was higher after the low fibre meal, and the area under the glycaemic curve significantly greater (226 (23.1) v 160 (20.0) mmol/min/dl-1, p < 0.05). No difference was found in satiety or fullness feelings, but hunger returned more rapidly after the low fibre meal. In conclusion, fibre naturally present in food delays gastric emptying of a solid meal, reduces the glycaemic response, and delays the return of hunger.


Asunto(s)
Glucemia/metabolismo , Fibras de la Dieta/administración & dosificación , Vaciamiento Gástrico , Adulto , Femenino , Alimentos , Humanos , Hambre , Masculino , Antro Pilórico/anatomía & histología , Factores de Tiempo
3.
Scand J Gastroenterol ; 30(4): 392-8, 1995 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-7610357

RESUMEN

BACKGROUND: This study was aimed to investigate the effect of long-term treatment with high-protease pancreatic extract on the recurrent abdominal pain of patients with chronic pancreatitis. METHODS: Twenty-six patients with a firm diagnosis of chronic pancreatitis and a pattern of recurrent pain were recruited and randomly assigned to treatment with pancreatic extract (Pancrex-Duo capsules, each containing 34,375 USP units of protease in enteric-coated microspheres) or placebo, at a dose of four capsules four times daily, for 4 months. At the end of the first period patients were switched to the other medication for the next 4 months. Four patients did not complete the study because of unbearable recurring pain or inadequate compliance with treatment. The other 22 patients daily recorded the presence, intensity, and duration of pain and the consumption of analgesics, for 8 months. RESULTS: No difference was found when intraindividual records during placebo and extract treatment periods were compared. Conversely, in the second 4 months of follow-up, regardless of the treatment given in the first period, there was a significant reduction in the cumulative pain score (median, 95; range, 0-1005, versus 134; 0-972; p < 0.05), in the number of days (8; 0-132, versus 13; 0-126; p < 0.02) and hours (54; 0-680, versus 80; 0-602; p < 0.05) of pain, and in the analgesic consumption score (0; 0-22, versus 12; 0-44; p = 0.02). CONCLUSIONS: Chronic supplementation with pancreatic extract is not beneficial in the management of recurrent pain in patients with chronic pancreatitis.


Asunto(s)
Dolor Abdominal/terapia , Extractos Pancreáticos/uso terapéutico , Pancreatitis/complicaciones , Dolor Abdominal/etiología , Adulto , Anciano , Análisis de Varianza , Colecistoquinina/sangre , Enfermedad Crónica , Estudios Cruzados , Método Doble Ciego , Femenino , Humanos , Masculino , Persona de Mediana Edad , Dimensión del Dolor , Extractos Pancreáticos/administración & dosificación , Pancreatitis/sangre , Recurrencia , Factores de Tiempo
4.
Scand J Gastroenterol ; 28(8): 749-52, 1993 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-8210993

RESUMEN

Tube feeding nutrition, either elemental or polymeric, is increasingly used in patients with digestive problems. Pancreatic insufficiency is a widely accepted indication for the use of an elemental formula, which requires less residual digestive capacity. To confirm this assumption, we have compared the absorption of elemental and polymeric diets and the effect of exogenous pancreatic enzymes in a patient on long-term total enteral feeding after total pancreatectomy. Malabsorption of both formulas was observed without enzyme supplementation. A marked improvement of fat and nitrogen absorption was obtained when pancreatic enzymes were added to both enteral diets. It is concluded that pancreatic enzymes should always be added to liquid diets in pancreatic insufficiency. No clear advantage is to be anticipated by the use of elemental as compared with polymeric diets.


Asunto(s)
Nutrición Enteral , Insuficiencia Pancreática Exocrina/terapia , Alimentos Formulados , Extractos Pancreáticos/uso terapéutico , Femenino , Humanos , Absorción Intestinal/fisiología , Persona de Mediana Edad , Pancreatectomía , Cuidados Posoperatorios
5.
Clin Ter ; 142(5): 445-51, 1993 May.
Artículo en Italiano | MEDLINE | ID: mdl-8339528

RESUMEN

In vitro behaviour of the enteric-coating of a new pancreatic enzyme containing preparation in enteric-coated microtablets was evaluated, by incubating at 37 degrees C, under gentle agitation, the preparation under study in buffered gastric (pH 2, 3, 4, 5, 6) and in buffered duodenal juice (pH 3, 4, 5, 6, 7, 8) for 30, 60, 90, 120 minutes. Lipase and chymotripsin activities were measured at each time and pH in the solution and in the undissolved microtablets. The drug under study showed a good enteric-coating, preserving about 100% of the enzyme content, when incubated in buffered gastric juice, up to pH 6, and releasing in the solution, during incubation in buffered duodenal juice, 75% of its enzyme content at pH 7 and 8. Therefore, the pancreatic enzymes contained in this new enteric-coated microtablet preparation are well protected against inactivation from acid and are bioavailable for digestion of alimentary substrates at optimal or near optimal pH in duodenal juice.


Asunto(s)
Quimotripsina/metabolismo , Insuficiencia Pancreática Exocrina/tratamiento farmacológico , Lipasa/metabolismo , Disponibilidad Biológica , Tampones (Química) , Evaluación de Medicamentos , Duodeno/metabolismo , Insuficiencia Pancreática Exocrina/enzimología , Jugo Gástrico/metabolismo , Humanos , Concentración de Iones de Hidrógeno , Técnicas In Vitro , Secreciones Intestinales/metabolismo , Comprimidos Recubiertos
6.
Int J Pancreatol ; 8(4): 279-87, 1991 May.
Artículo en Inglés | MEDLINE | ID: mdl-1724259

RESUMEN

Thirty-four patients with chronic calcified pancreatitis were evaluated clinically and biochemically (at a time when painful relapses were not present) every 9 mo for 3 yr; 25 of them were also studied at 4 and 9 yr. Serum elastase-1, trypsin, lipase, and amylase in the same sera were measured at each visit; levels on entry and variations during the study were compared with the clinical and functional data of the patients. On entry, low levels of elastase-1 were found in 11.7% of the patients, high levels in 41.1%; in contrast, high levels of trypsin and lipase were found in only a small number of patients (5.8 and 11.7%, respectively), whereas low levels were present in a substantial number (47.8 and 32.3% for trypsin and lipase, respectively). Over time, we found a significant (p = 0.000002) reduction in elastase-1 levels. Such reduction was not found for trypsin, lipase, or amylase. The reduction of serum elastase-1 was significantly (p less than 0.003) more frequent in patients presenting a reduction in painful relapses than in patients with a stable or increased attach rate; this association was weaker (p less than 0.05) for lipase and trypsin, and absent for amylase. No correlation was found between circulating enzymes and either alcohol consumption or age of patients. In patients with severe exocrine impairment, low levels of elastase were found in only 20% of the cases, whereas trypsin and lipase were reduced in 73.3 and 53.3% of the cases, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Amilasas/sangre , Lipasa/sangre , Elastasa Pancreática/sangre , Pancreatitis/enzimología , Tripsina/sangre , Consumo de Bebidas Alcohólicas , Calcinosis , Enfermedad Crónica , Humanos , Estadística como Asunto , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA